Cargando…
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature
OBJECTIVE: Wiskott–Aldrich syndrome (WAS) is a rare X‐linked primary immunodeficiency, characterized by micro‐thrombocytopenia, recurrent infections, and eczema. This study aims to describe common oral manifestations and evaluate oral microbioma of WAS patients. MATERIAL AND METHODS: In this cohort...
Autores principales: | Lucchese, Alessandra, Cenciarelli, Sabina, Manuelli, Maurizio, Marcolina, Marta, Barzaghi, Federica, Calbi, Valeria, Migliavacca, Maddalena, Bernardo, Maria Ester, Tucci, Francesca, Gallo, Vera, Fraschetta, Federico, Darin, Silvia, Casiraghi, Miriam, Aiuti, Alessandro, Ferrua, Francesca, Cicalese, Maria Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874040/ https://www.ncbi.nlm.nih.gov/pubmed/35199474 http://dx.doi.org/10.1002/cre2.503 |
Ejemplares similares
-
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report
por: Cenciarelli, Sabina, et al.
Publicado: (2020) -
A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation
por: Consiglieri, Giulia, et al.
Publicado: (2021) -
A novel genomic inversion in Wiskott-Aldrich–associated autoinflammation
por: Brigida, Immacolata, et al.
Publicado: (2016) -
Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome
por: Sereni, Lucia, et al.
Publicado: (2019) -
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
por: Ferrua, Francesca, et al.
Publicado: (2019)